Table 2.
The findings of the GO analysis, which comprised the top 10 MF, top 10 CC, and top 10 BP.
| GO term | Gene ratio | Ontology |
|---|---|---|
| Signal transduction | 10 | BP |
| Negative regulation of the apoptotic process | 8 | BP |
| Positive regulation of transcription from RNA polymerase II promoter | 6 | BP |
| Oxidation-reduction process | 6 | BP |
| Response to drug | 6 | BP |
| Proteolysis | 5 | BP |
| Protein phosphorylation | 5 | BP |
| Cell proliferation | 5 | BP |
| Positive regulation of ERK1 and ERK2 cascade | 5 | BP |
| Response to hypoxia | 5 | BP |
| Cytosol | 18 | CC |
| Cytoplasm | 17 | CC |
| Plasma membrane | 16 | CC |
| Nucleus | 16 | CC |
| Extracellular exosome | 15 | CC |
| Nucleoplasm | 14 | CC |
| Extracellular space | 12 | CC |
| Mitochondrion | 10 | CC |
| Membrane | 9 | CC |
| Extracellular region | 8 | CC |
| Protein binding | 27 | MF |
| ATP binding | 9 | MF |
| Protein kinase activity | 7 | MF |
| Identical protein binding | 7 | MF |
| Enzyme binding | 6 | MF |
| Zinc ion binding | 6 | MF |
| Receptor binding | 5 | MF |
| Protein serine/threonine kinase activity | 5 | MF |
| Protein heterodimerization activity | 5 | MF |
| Steroid binding | 4 | MF |